Excess Costs and Utilization Associated with Methicillin Resistance for Patients with Staphylococcus aureus Infection

被引:126
作者
Filice, Gregory A. [1 ,2 ]
Nyman, John A. [3 ]
Lexau, Catherine [4 ]
Lees, Christine H. [4 ]
Bockstedt, Lindsay A. [3 ]
Como-Sabetti, Kathryn [4 ]
Lesher, Lindsey J. [4 ]
Lynfield, Ruth [4 ]
机构
[1] Univ Minnesota, Sch Med, Div Infect Dis, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Publ Hlth, Infect Dis Sect, Med Serv,Vet Affairs Med Ctr, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA
[4] Minnesota Dept Hlth, St Paul, MN USA
关键词
BLOOD-STREAM INFECTIONS; ECONOMIC-IMPACT; UNITED-STATES; BACTEREMIA; OUTCOMES; HOSPITALS; HEALTH; EPIDEMIOLOGY; MORBIDITY; BURDEN;
D O I
10.1086/651094
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. To determine differences in healthcare costs between cases of methicillin-susceptible Staphylococcus aureus (MSSA) infection and methicillin-resistant S. aureus (MRSA) infection in adults. DESIGN. Retrospective study of all cases of S. aureus infection. SETTING. Department of Veterans Affairs hospital and associated clinics. PATIENTS. There were 390 patients with MSSA infections and 335 patients with MRSA infections. METHODS. We used medical records, accounting systems, and interviews to identify services rendered and costs for Minneapolis Veterans Affairs Medical Center patients with S. aureus infection with onset during the period from January 1, 2004, through June 30, 2006. We used regression analysis to adjust for patient characteristics. RESULTS. Median 6-month unadjusted costs for patients infected with MRSA were $34,657, compared with $15,923 for patients infected with MSSA. Patients with MRSA infection had more comorbidities than patients with MSSA infection (mean Charlson index 4.3 vs 3.2; P < .001). For patients with Charlson indices of 3 or less, mean adjusted 6-month costs derived from multivariate analysis were $51,252 (95% CI, $46,041-$56,464) for MRSA infection and $30,158 (95% CI, $27,092-$33,225) for MSSA infection. For patients with Charlson indices of 4 or more, mean adjusted costs were $84,436 (95% CI, $79,843-$89,029) for MRSA infection and $59,245 (95% CI, $56,016-$62,473) for MSSA infection. Patients with MRSA infection were also more likely to die than were patients with MSSA infection (23.6% vs 11.5%; P < .001). MRSA infection was more likely to involve the lungs, bloodstream, and urinary tract, while MSSA infection was more likely to involve bones or joints; eyes, ears, nose, or throat; surgical sites; and skin or soft tissue (P < .001). CONCLUSIONS. Resistance to methicillin in S. aureus was independently associated with increased costs. Effective antimicrobial stewardship and infection prevention programs are needed to prevent these costly infections.
引用
收藏
页码:365 / 373
页数:9
相关论文
共 36 条
[1]  
[Anonymous], 1999, DOCUMENT M100 S9
[2]  
[Anonymous], 2004, HOSP EPIDEMIOLOGY IN
[3]   METHICILLIN-RESISTANT STAPHYLOCOCCI [J].
BARBER, M .
JOURNAL OF CLINICAL PATHOLOGY, 1961, 14 (04) :385-&
[4]   Determination of VA health care costs [J].
Barnett, PG .
MEDICAL CARE RESEARCH AND REVIEW, 2003, 60 (03) :124S-141S
[5]   Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997-2007 [J].
Burton, Deron C. ;
Edwards, Jonathan R. ;
Horan, Teresa C. ;
Jernigan, John A. ;
Fridkin, Scott K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (07) :727-736
[6]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]  
Chu Vivian H, 2005, Am J Med, V118, P1416, DOI 10.1016/j.amjmed.2005.06.011
[9]   The impact of antimicrobial resistance on health and economic outcomes [J].
Cosgrove, SE ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :1433-1437
[10]   The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].
Cosgrove, SE ;
Qi, YL ;
Kaye, KS ;
Harbarth, S ;
Karchmer, AW ;
Carmeli, Y .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174